Article Information
PubMed
Print ISSN
Online ISSN
History
- Received August 18, 2022
- Accepted January 12, 2023
- Published online May 17, 2023.
Article Versions
- Earlier version (January 20, 2023 - 12:08).
- Earlier version (February 22, 2023 - 11:36).
- You are viewing the most recent version of this article.
Copyright & Usage
U.S. Government work not protected by U.S. copyright.
Author Information
- Michael R. Chojnacki,
- Eric B. Thorndike,
- John S. Partilla,
- Kenner C. Rice,
- Charles W. Schindler, and
- Michael H. Baumann
- Designer Drug Research Unit (M.R.C., J.S.P., C.W.S., M.H.B.) and Preclinical Pharmacology Section (E.B.T., C.W.S.), National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland; and Drug Design and Synthesis Section, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism Intramural Research Programs, Rockville, Maryland (K.C.R.)
- Address correspondence to:
Dr. Charles W. Schindler, Designer Drug Research Unit, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, 251 Bayview Boulevard, Baltimore, MD 21224. E-mail: cschind{at}helix.nih.gov
Statistics from Altmetric.com
Article usage
In this issue
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement